Skip to main content
. 2020 Jan 27;11(1):69. doi: 10.1038/s41419-020-2266-x

Fig. 6. Downregulation of SETD2 expression in SETD2-competent ACHN cells lead to increase of an accumulation of free ATG12 and ATG12 complexes and decrease in LC3-II lipidation.

Fig. 6

ad Downregulation of SETD2 expression in the SETD2-competent ACHN cells was achieved by small-interfering RNA targeting SETD2. a Immunoblot analysis for SETD2 confirm the reduction in SETD2 expression in ACHN cells upon treatment with a siRNA directed against SETD2 for 48 h. b Immunoblot analysis of ATG12 protein reveals that the downregulation of SETD2 expression in the ACHN SETD2-competent cells promotes the increase in free ATG12 and ATG12-associated complexes. c Analysis of LC3B expression in upon downregulation of SETD2 expression. Bafilomycin A1 (40 nm) was used for 4 h treatment. d Quantification of LC3-II levels normalized to actin. Bars represent the analysis of three independent experiments, error bars represent SEM; ***p ≤ 0.001.